Bayforest Capital’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,153
Closed -$135K 1035
2026
Q1
$135K Sell
3,153
-904
-22% -$38.9K 0.15% 259
2025
Q4
$178K Sell
4,057
-9,706
-71% -$402K 0.13% 318
2025
Q3
$568K Sell
13,763
-9,814
-42% -$394K 0.27% 106
2025
Q2
$1.04M Sell
23,577
-1,663
-7% -$66.5K 0.45% 31
2025
Q1
$932K Buy
+25,240
New +$899K 0.41% 45

Other funds holding EXEL

Bayforest Capital's EXEL Position: Q2 2026 in Review

Bayforest Capital sold out of Exelixis (EXEL) in Q2 2026, closing a stake of 3,153 shares — an estimated $135K sold.

Bayforest Capital first reported a position in EXEL in Q1 2025 and held it in 5 quarters. The position peaked at $1.04M in Q2 2025. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Bayforest Capital reported no remaining Exelixis position as of Q2 2026 after selling out during the quarter.
  • Bayforest Capital sold 3,153 Exelixis shares in Q2 2026, an estimated $135K.
  • Bayforest Capital first reported a position in Exelixis in Q1 2025 and held it in 5 quarters.
  • Bayforest Capital's Exelixis position peaked at $1.04M in Q2 2025.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.